Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Agios Pharmaceuticals (AGIO) Return on Capital Employed (2016 - 2025)

Agios Pharmaceuticals' Return on Capital Employed history spans 13 years, with the latest figure at 0.37% for Q4 2025.

  • For Q4 2025, Return on Capital Employed fell 12.0% year-over-year to 0.37%; the TTM value through Dec 2025 reached 0.37%, down 12.0%, while the annual FY2025 figure was 0.34%, 1.0% up from the prior year.
  • Return on Capital Employed reached 0.37% in Q4 2025 per AGIO's latest filing, down from 0.35% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.17% in Q2 2021 to a low of 0.54% in Q2 2024.
  • Average Return on Capital Employed over 5 years is 0.33%, with a median of 0.33% recorded in 2022.
  • Peak YoY movement for Return on Capital Employed: skyrocketed 32bps in 2021, then fell -19bps in 2024.
  • A 5-year view of Return on Capital Employed shows it stood at 0.26% in 2021, then dropped by -28bps to 0.34% in 2022, then dropped by -28bps to 0.43% in 2023, then soared by 40bps to 0.26% in 2024, then tumbled by -45bps to 0.37% in 2025.
  • Per Business Quant, the three most recent readings for AGIO's Return on Capital Employed are 0.37% (Q4 2025), 0.35% (Q3 2025), and 0.32% (Q2 2025).